Top compounds associated with response to PRR20C


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.012 0.7
mRNA linifanib CTRPv2 pan-cancer AAC -0.012 0.7
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC -0.013 0.7
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.7
mRNA CD-437 CTRPv2 pan-cancer AAC -0.011 0.7
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
mRNA neratinib CTRPv2 pan-cancer AAC -0.012 0.7
mRNA lapatinib UHNBreast pan-cancer AAC -0.1 0.7
mRNA GDC-0941 gCSI pan-cancer AAC -0.013 0.7
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC -0.024 0.7
Download CSV